Gliknik, Inc., a biopharmaceuticals company, develops therapies for patients with cancer and immune disorders. Its Immunomodulator Platform involves in off-the-shelf peptide drugs that increase CD4, CD8, and antibody immune responses against cancer; Stradomer Platform produces drugs designed to mimic the eficacy of pooled human intravenousimmunoglobulin; and Stradobody Platform produces compounds that are similar to moncolonal antibodies for tumor cell killing. The company was founded in 2007 and is based in Baltimore, Maryland.

Health Care

Biotechnology

GLIKNIK INC.

GLIKNIK INC.'s headquarters in Baltimore, MD, United States

David S. Block

Henrik S. Olsen

This department manages the oversight and strategic direction of the organization through its board of directors.

GLIKNIK INC.

Org chart

Teams

Board Governance

Offices

GLIKNIK INC.

Org chart

Teams

Board Governance

Offices

Related companies